Advanced company searchLink opens in new window

OPHTHOVANT HOLDINGS LIMITED

Company number 11007375

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
12 Mar 2024 GAZ2(A) Final Gazette dissolved via voluntary strike-off
26 Dec 2023 GAZ1(A) First Gazette notice for voluntary strike-off
18 Dec 2023 DS01 Application to strike the company off the register
24 Oct 2023 CS01 Confirmation statement made on 10 October 2023 with updates
06 Oct 2023 AP01 Appointment of Ms Emma Carys Price as a director on 6 October 2023
06 Oct 2023 TM01 Termination of appointment of Mark Craig as a director on 6 October 2023
05 Oct 2023 SH19 Statement of capital on 5 October 2023
  • USD 0.20565
05 Oct 2023 SH20 Statement by Directors
05 Oct 2023 CAP-SS Solvency Statement dated 29/09/23
05 Oct 2023 RESOLUTIONS Resolutions
  • RES13 ‐ Reduce share prem a/c 29/09/2023
  • RES06 ‐ Resolution of reduction in issued share capital
09 Mar 2023 SH01 Statement of capital following an allotment of shares on 6 March 2023
  • USD 20,565
19 Dec 2022 AA Accounts for a small company made up to 31 March 2022
31 Oct 2022 CS01 Confirmation statement made on 10 October 2022 with updates
12 Oct 2022 AD01 Registered office address changed from Suite 1, 3rd Floor 11 - 12 st. James's Square London SW1Y 4LB United Kingdom to 7th Floor 50 Broadway London SW1H 0DB on 12 October 2022
25 Apr 2022 PSC02 Notification of Roivant Sciences Ltd. as a person with significant control on 1 October 2021
22 Apr 2022 PSC09 Withdrawal of a person with significant control statement on 22 April 2022
08 Apr 2022 SH01 Statement of capital following an allotment of shares on 31 March 2022
  • USD 20,564
17 Dec 2021 AA Full accounts made up to 31 March 2021
19 Oct 2021 CS01 Confirmation statement made on 10 October 2021 with updates
31 Mar 2021 SH01 Statement of capital following an allotment of shares on 31 March 2021
  • USD 20,563
31 Mar 2021 SH01 Statement of capital following an allotment of shares on 31 March 2021
  • USD 20,563
27 Oct 2020 AA Full accounts made up to 31 March 2020
12 Oct 2020 CS01 Confirmation statement made on 10 October 2020 with no updates
01 Nov 2019 TM01 Termination of appointment of Evia Mary Soussi as a director on 1 November 2019
01 Nov 2019 AP01 Appointment of Mr Mark Craig as a director on 1 November 2019